Maura Buttiglione

Dr. Maura Buttiglione

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in NeuroImage
Verified
Journal Article
Closed access
Claudio BabiloniClaudio Babiloni
Claudio Babiloni
GFGiovanni B. Frisoni
Giovanni B. Frisoni
MPMichela Pievani
Michela Pievani
Fabrizio VecchioFabrizio Vecchio
Fabrizio Vecchio
RLRoberta Lizio
Roberta Lizio
PRPaolo M Rossini
Paolo M Rossini

1 August 2015 in Brain Research
Verified
Journal Article
Closed access
DMDavide Martino
Davide Martino
Panagiotis ZisPanagiotis Zis
Panagiotis Zis
MBMaura Buttiglione
Maura Buttiglione

8 June 2007 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MBMaura Buttiglione
Maura Buttiglione
LRL. Roca
L. Roca
EME. Montemurno
E. Montemurno
FVF. Vitiello
F. Vitiello
VCV. Capozzi
V. Capozzi
GCG. Cibelli
G. Cibelli

1 January 2003 in Development
Verified
Journal Article
Closed access
ABAntonella Bizzoca
Antonella Bizzoca
DVDaniela Virgintino
Daniela Virgintino
LLLoredana Lorusso
Loredana Lorusso
MBMaura Buttiglione
Maura Buttiglione
LYLynn Yoshida
Lynn Yoshida
Gianfranco GENNARINIGianfranco GENNARINI
Gianfranco GENNARINI
F3/contactin (CNTN1) and TAG-1 (CNTN2) are closely related axonal glycoproteins that are differentially regulated during development. In the cerebellar cortex TAG-1 is expressed first as granule cell progenitors differentiate in the premigratory zone of the external germinal layer. However, as these cells begin radial migration, TAG-1 is replaced by F3/contactin. To address the significance of this differential regulation, we have generated transgenic mice in which F3/contactin expression is driven by TAG-1 gene regulatory sequences, which results in premature expression of F3/contactin in granule cells. These animals (TAG/F3 mice) display a developmentally regulated cerebellar phenotype in which the size of the cerebellum is markedly reduced during the first two postnatal weeks but subsequently recovers. This is due in part to a reduction in the number of granule cells, most evident in the external germinal layer at postnatal day 3 and in the inner granular layer between postnatal days 8 and 11. The reduction in granule cell number is accompanied by a decrease in precursor granule cell proliferation at postnatal day 3, followed by an increase in the number of cycling cells at postnatal day 8. In the same developmental window the size of the molecular layer is markedly reduced and Purkinje cell dendrites fail to elaborate normally. These data are consistent with a model in which deployment of F3/contactin on granule cells affects proliferation and differentiation of these neurons as well as the differentiation of their synaptic partners, the Purkinje cells. Together, these findings indicate that precise spatio-temporal regulation of TAG-1 and F3/contactin expression is critical for normal cerebellar morphogenesis.

25 September 2008 in Human Brain Mapping
Verified
Journal Article
Closed access
Claudio BabiloniClaudio Babiloni
Claudio Babiloni
Fabrizio VecchioFabrizio Vecchio
Fabrizio Vecchio
Giovanni MirabellaGiovanni Mirabella
Giovanni Mirabella
MBMaura Buttiglione
Maura Buttiglione
FSFabio Sebastiano
Fabio Sebastiano
FEFabrizio Eusebi
Fabrizio Eusebi

17 June 2011 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
DMDavide Martino
Davide Martino
FCFlavia Chiarotti
Flavia Chiarotti
MBMaura Buttiglione
Maura Buttiglione
FCFrancesco Cardona
Francesco Cardona
RCRoberta Creti
Roberta Creti
OGON BEHALF OF THE ITALIAN TOURETTE SYNDROME STUDY GROUP
ON BEHALF OF THE ITALIAN TOURETTE SYNDROME STUDY GROUP
To evaluate the relationship between diagnosis and clinical course of Tourette syndrome and group A Streptococcus (GAS). GAS infections, anti-streptococcal, and anti-basal ganglia antibodies (ABGA) were compared between 168 patients (136 males, 32 females) with Tourette syndrome; (median [range] age [25th-75th centile] 10y [8-11y]); median Tourette syndrome duration (25th-75th centile), 3y (1y 3mo-5y 9mo) and a comparison group of 177 patients (117 males, 60 females) with epileptic or sleep disorders median age [25th-75th centile], 10y [8y-1y 6mo]). One hundred and forty-four patients with Tourette syndrome were followed up at 3-month intervals; exacerbations of tics, obsessive-compulsive symptoms, and other psychiatric comorbidities were defined by a bootstrap procedure. The effect of new GAS infections and identification of new ABGA upon risk of exacerbation was assessed using logistic regression analysis. Cross-sectionally, patients with Tourette syndrome exhibited a higher frequency of GAS infection (8% vs 2%; p=0.009), higher anti-streptolysin O (ASO) titres (246 [108-432] vs 125 [53-269]; p0.05). Patients with Tourette syndrome might be more prone to GAS infections and develop stronger antibody responses to GAS, probably as a result of underlying immune dysregulation. New GAS infections are unlikely to exert, years after their onset, a major effect upon the severity of neuropsychiatric symptoms.